2m 2m 2m 2m 2m 2m 2m
RELMADA THERAPEU (RLMD)
NASDAQ
$6.47+$0.01 (+0.23%)
Price as of Jul 14, 2026 5:29 AM EDT- $677.2MMarket Cap
- 927.89%1-Year Change
- BiotechnologyIndustry
RELMADA THERAPEU (RLMD)
$6.47+$0.01 (+0.23%)
Earnings Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | 1 | ||
Low Earnings Volatility | 1 |
Momentum Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | -8.99% | ||
12-Month Momentum | 945.90% | ||
3-Month Risk Adjusted Momentum | -32.48% | ||
12-Month Risk Adjusted Momentum | 804.89% |
True Yield
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | 0.46% | ||
Net Debt Paydown Yield | N/A |
Financial Health Score
Valuation | RLMD | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 1 |